Abstract
The NIH awarded research grants to five academic medical centers to create new clinical sites, in an expansion of its Undiagnosed Diseases Network (UDN) that will include a new metabolomics core, and increased model organism capabilities.
The five new clinical sites are: Children’s Hospital of Philadelphia and the Hospital of University of Pennsylvania; University of Miami School of Medicine; University of Utah, Salt Lake City; University of Washington School of Medicine, Seattle, and Seattle Children’s Hospital; and Washington University in St. Louis.
The grants are intended to help the new sites improve and accelerate the diagnosis of rare and undiagnosed conditions, the agency said—and were made as part of the second phase of the UDN, to which the NIH has committed a total of approximately $100 million over four years.
gerenme / Getty Images
